Rigid Endoscopes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Rigid endoscopes are straight, hollow metal tubes that are used to examine the interior of a hollow organ or cavity of the body. The rigid endoscopes market research report provides comprehensive information about the rigid endoscopes pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Moreover, the rigid endoscopes report provides information about various pipeline products and their estimated approval dates.

What are the key regulatory paths in the rigid endoscopes pipeline products market?

The rigid endoscopes pipeline report provides detailed insights into the pipeline products by a regulatory path including 510(k), TGA, and CE.

Rigid Endoscopes Pipeline Products Market Analysis by Regulatory Path

Rigid Endoscopes Pipeline Products Market Analysis by Regulatory Path

To know more about regulatory paths, download a free report sample

What are the key segments in the rigid endoscopes pipeline products market?

The key segment in the rigid endoscopes pipeline products market is traditional rigid laparoscopes.

What are the key territories in the rigid endoscopes pipeline products market?

The key territories in the rigid endoscopes pipeline products market are the US, Australia, Israel, and Europe. The US is the leading territory in the rigid endoscopes pipeline products market.

Rigid Endoscopes Pipeline Products Market Analysis by Territories

Rigid Endoscopes Pipeline Products Market Analysis by Territories

For more territory insights, download a free report sample

Which are the key companies in the rigid endoscopes pipeline products market?

Some of the key companies in the rigid endoscopes pipeline products market are 3rd Stone Design Inc, Aequorea Vision Medical, Inc. (Inactive), Ben-Gurion University of the Negev, Endoways SA, Image In, Johns Hopkins University, King’s College London, Micro-Invasive Technology, Inc. (Inactive), Optiscan Imaging Ltd, Optiscope Technologies Ltd, and the University of Arizona.

Ben-Gurion University of the Negev

Ben-Gurion University of the Negev (Ben-Gurion University) is a public research university that offers educational and research programs and services. The university offers services such as undergraduate and graduate degrees, research in the field of green energy, alternative and renewable energy including renewable fuels and solar energy, environmental research, laboratories services, national and multi-disciplinary research services. It also provides biotechnology, nanoscale science and technology, research and development, industry, health care, economy, society, culture, educational services, health science, and desert research services. Ben-Gurion University offers studies in psychology, sociology, and anthropology, academic courses, administration services, and sports center services, among others. Ben-Gurion University is headquartered in Beersheba, Israel

Johns Hopkins University

Johns Hopkins University (JHU) is a research university that offers undergraduate, graduate, master’s, and doctoral programs. It offers educational services in the areas of arts and sciences, engineering, business, medicine, nursing, public health, and advanced international studies. It also conducts research and development programs on applied physics, projects administration, natural sciences, engineering, technology, global research, and others. JHU provides undergraduate and postgraduate research services through its incubation center in the areas of drug development for cancer, mobile health platform, and device for detecting and preventing blindness caused by diabetes. JHU is headquartered in Baltimore, Maryland, the US.

University of Arizona

University of Arizona (UA) is a research university that offers undergraduate and graduate degrees. The university’s academic departments include cancer biology graduate interdisciplinary program, cancer biology, cellular and molecular medicine, cancer center, center for educational resources in culture, center for applied sociology, language and literacy, academic affairs, college of engineering, college of medicine, accounting, and agricultural and biosystems engineering. It also provides health services and a medical center for students and employees. UA offers educational services in the areas of space sciences, optics, biosciences, arts and humanities, business, technology transfer, and others. It also operates museums. The university includes the College of Fine Arts, College of Humanities, College of Optical Sciences, College of Science, and Eller College of Management is operated under the University of Arizona. UA is headquartered in Tucson, Arizona, the US.

Market report scope

Key regulatory paths 510(k), TGA, and CE
Key territories The US, Australia, Israel, and Europe
Key segment Traditional Rigid Laparoscopes
Key companies 3rd Stone Design Inc, Aequorea Vision Medical, Inc. (Inactive), Ben-Gurion University of the Negev, Endoways SA, Image In, Johns Hopkins University, King’s College London, Micro-Invasive Technology, Inc. (Inactive), Optiscan Imaging Ltd, Optiscope Technologies Ltd, and University of Arizona

 Scope

  • Extensive coverage of the rigid endoscopes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of rigid endoscopes and lists all their pipeline projects
  • The coverage of pipeline products is based on various stages of development ranging from early development to approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Identify and understand important and diverse types of rigid endoscopes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

3rd Stone Design Inc
Aequorea Vision Medical, Inc. (Inactive)
Ben-Gurion University of the Negev
Endoways SA
Image In
Johns Hopkins University
King's College London
Micro-Invasive Technology, Inc. (Inactive)
Optiscan Imaging Ltd
Optiscope Technologies Ltd
University of Arizona

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Rigid Endoscopes Overview 8

3 Products under Development 9

3.1 Rigid Endoscopes – Pipeline Products by Stage of Development 9

3.2 Rigid Endoscopes – Pipeline Products by Segment 10

3.3 Rigid Endoscopes – Pipeline Products by Territory 11

3.4 Rigid Endoscopes – Pipeline Products by Regulatory Path 12

3.5 Rigid Endoscopes – Pipeline Products by Estimated Approval Date 13

3.6 Rigid Endoscopes – Ongoing Clinical Trials 14

4 Rigid Endoscopes – Pipeline Products under Development by Companies 15

4.1 Rigid Endoscopes Companies – Pipeline Products by Stage of Development 15

4.2 Rigid Endoscopes – Pipeline Products by Stage of Development 16

5 Rigid Endoscopes Companies and Product Overview 17

5.1 3rd Stone Design Inc Company Overview 17

5.1.1 3rd Stone Design Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Aequorea Vision Medical, Inc. (Inactive) Company Overview 20

5.2.1 Aequorea Vision Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 Ben-Gurion University of the Negev Company Overview 23

5.3.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 Endoways SA Company Overview 24

5.4.1 Endoways SA Pipeline Products & Ongoing Clinical Trials Overview 24

5.5 Image In Company Overview 25

5.5.1 Image In Pipeline Products & Ongoing Clinical Trials Overview 25

5.6 Johns Hopkins University Company Overview 26

5.6.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 King’s College London Company Overview 27

5.7.1 King’s College London Pipeline Products & Ongoing Clinical Trials Overview 27

5.8 Micro-Invasive Technology, Inc. (Inactive) Company Overview 28

5.8.1 Micro-Invasive Technology, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

5.9 Optiscan Imaging Ltd Company Overview 29

5.9.1 Optiscan Imaging Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 Optiscope Technologies Ltd Company Overview 33

5.10.1 Optiscope Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

5.11 University of Arizona Company Overview 34

5.11.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 34

6 Rigid Endoscopes- Recent Developments 36

6.1 Feb 24, 2022: Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results 36

6.2 Feb 24, 2022: LeMaitre Q4 2021 Financial Results 37

6.3 Feb 11, 2022: LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022 38

6.4 Jan 26, 2022: CONMED Announces Fourth Quarter and Full-Year 2021 Financial Results 39

6.5 Jan 20, 2022: Intuitive Announces Fourth Quarter Earnings 39

6.6 Jan 12, 2022: Intuitive Announces Preliminary Fourth Quarter and Full Year 2021 Results 41

6.7 Jan 11, 2022: Integra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2021 Revenue and Plans $125 Million Share Repurchase 42

6.8 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 43

6.9 Dec 03, 2021: i360medical Confirms Untimely Passing Of CEO Derek Young 44

6.10 Nov 18, 2021: Teleflex to Participate in the 33rd Annual Virtual Piper Sandler Healthcare Conference 44

6.11 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule 44

6.12 Oct 28, 2021: Teleflex Reports Third Quarter 2021 Results and Full Year Outlook 45

6.13 Oct 28, 2021: LeMaitre Q3 2021 Financial Results 49

6.14 Oct 28, 2021: Merit Medical Reports Results For Quarter Ended September 30, 2021 50

6.15 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021 51

6.16 Oct 27, 2021: CONMED Announces Third Quarter Financial Results 55

6.17 Oct 25, 2021: OptiScan Imaging : Receipt of R&D tax incentive rebate 56

6.18 Oct 19, 2021: Intuitive Announces Third Quarter Earnings 2021 56

6.19 Oct 19, 2021: Intuitive Announces Executive Leadership Changes 58

6.20 Oct 14, 2021: Teleflex Announces Third Quarter 2021 Earnings Conference Call Information 58

6.21 Oct 14, 2021: LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021 58

6.22 Oct 05, 2021: Teijin to Exhibit Carbon Fiber and Aramid Solutions at CAMX 59

6.23 Oct 05, 2021: Merit Medical Systems to Announce Third Quarter Results on October 28, 2021 59

6.24 Sep 30, 2021: Change to Executive Board of Carl Zeiss Meditec 59

6.25 Sep 24, 2021: Teijin to Exhibit at China International Import Expo 61

6.26 Sep 15, 2021: Surgical Innovations Group Announces Interim results for the six-months ended 30 June 2021 61

6.27 Sep 09, 2021: Merit Medical Systems to Announce First Quarter Results on April 29, 2021 63

6.28 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting 63

6.29 Sep 02, 2021: Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences 63

6.30 Sep 02, 2021: Integra LifeSciences Announces Participation In Upcoming Investor Conferences 63

6.31 Sep 01, 2021: Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference 63

6.32 Aug 26, 2021: Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference 64

6.33 Jul 29, 2021: Smith+Nephew Second Quarter and First Half 2021 Results 64

6.34 Jul 29, 2021: LeMaitre Q2 2021 Financial Results 65

6.35 Jul 29, 2021: Smith & Nephew announces Half-year Report 66

6.36 Jul 28, 2021: Integra LifeSciences Reports Second Quarter 2021 Financial Results 67

6.37 Jul 28, 2021: Hologic Announces Financial Results for Third Quarter of Fiscal 2021 69

6.38 Jul 28, 2021: CONMED Announces financial results for the second quarter ended June 30, 2021 70

6.39 Jul 27, 2021: Stryker reports second quarter 2021 operating results 74

6.40 Jul 15, 2021: LeMaitre Will Announce Second Quarter 2021 Earnings Results on July 29, 2021 75

6.41 Jul 13, 2021: LeMaitre Provides Q2 2021 Update 75

6.42 Jul 09, 2021: Merit Medical Systems to Announce Second Quarter Results on July 29, 2021 76

6.43 Jul 07, 2021: Timing of Smith+Nephew Second Quarter Trading and First Half 2021 Results 76

6.44 May 24, 2021: Boston Scientific to Participate in Bernstein’s 37th Annual Strategic Decisions Conference 77

6.45 May 21, 2021: Surgical Innovations Group Posting of Annual Report & Accounts Notice of Annual General Meeting 77

6.46 May 20, 2021: Integra LifeSciences Hosts Virtual Investor Day 78

6.47 May 11, 2021: Precision Optics Corp. Schedules Third Quarter Fiscal Year 2021 Conference Call for Thursday, May 13, 2021 79

6.48 May 07, 2021: Integra LifeSciences To Host Virtual Investor Day On May 20, 2021 80

6.49 Apr 29, 2021: Teleflex Reports First Quarter 2021 Results 80

6.50 Apr 29, 2021: LeMaitre Q1 2021 Financial Results 84

6.51 Apr 28, 2021: CONMED Announces First Quarter Financial Results 85

6.52 Apr 28, 2021: Hologic Announces Financial Results for Second Quarter of Fiscal 2021 86

6.53 Apr 20, 2021: Intuitive announces financial results for the quarter ended March 31, 2021 87

6.54 Apr 14, 2021: LeMaitre Will Announce First Quarter 2021 Earnings Results on April 29, 2021 88

6.55 Apr 01, 2021: CONMED to Announce First Quarter 2021 Financial Results on April 28, 2021 88

6.56 Mar 29, 2021: Merit Medical Reports Results for Quarter Ended March 31, 2021 88

6.57 Mar 25, 2021: Surgical Innovations Group announces Final Results 90

6.58 Mar 23, 2021: CONMED Announces Annual Meeting of Stockholders 92

6.59 Mar 10, 2021: Teleflex to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum 92

7 Appendix 93

7.1 Methodology 93

7.2 About GlobalData 96

7.3 Contact Us 96

Table

Rigid Endoscopes – Pipeline Products by Stage of Development 9

Rigid Endoscopes – Pipeline Products by Segment 10

Rigid Endoscopes – Pipeline Products by Territory 11

Rigid Endoscopes – Pipeline Products by Regulatory Path 12

Rigid Endoscopes – Pipeline Products by Estimated Approval Date 13

Rigid Endoscopes – Ongoing Clinical Trials 14

Rigid Endoscopes Companies – Pipeline Products by Stage of Development 15

Rigid Endoscopes – Pipeline Products by Stage of Development 16

3rd Stone Design Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Pocket Colposcope – Product Status 17

Pocket Colposcope – Product Description 17

3rd Stone Design Inc – Ongoing Clinical Trials Overview 18

Pocket Colposcope – A Pilot Study Continuation to Assess the Use of an Introducer “Calla” During Cervical Cancer Screening 19

Pocket Colposcope – Cervical Cancer Detection Using Optical Spectroscopy 19

Pocket Colposcope – Compare the Performance of the Pocket Colposcope to VIA/VILI for Triage of HPV+ Women in Kenya 19

Aequorea Vision Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 20

AVM Surescreen Colposcope – Product Status 20

AVM Surescreen Colposcope – Product Description 20

AVM SureScreen Disposable Unit – Product Status 21

AVM SureScreen Disposable Unit – Product Description 21

AVM SureScreen Portable Unit – Product Status 21

AVM SureScreen Portable Unit – Product Description 22

Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 23

Robotic Endoscope – Product Status 23

Robotic Endoscope – Product Description 23

Endoways SA Pipeline Products & Ongoing Clinical Trials Overview 24

Trocamera System – Product Status 24

Trocamera System – Product Description 24

Image In Pipeline Products & Ongoing Clinical Trials Overview 25

Disposable Gastroscope – Product Status 25

Disposable Gastroscope – Product Description 25

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 26

3-D Endoscope – Product Status 26

3-D Endoscope – Product Description 26

King’s College London Pipeline Products & Ongoing Clinical Trials Overview 27

Vascular Imaging Optical Endoscope – Product Status 27

Vascular Imaging Optical Endoscope – Product Description 27

Micro-Invasive Technology, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

DIVA Semi-Rigid 5mm Endoscope – Product Status 28

DIVA Semi-Rigid 5mm Endoscope – Product Description 28

Optiscan Imaging Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

Optiscan Rigid Endoscope – Cervical Cancer – Product Status 29

Optiscan Rigid Endoscope – Cervical Cancer – Product Description 30

Optiscan Rigid Endoscope – Endometriosis – Product Status 30

Optiscan Rigid Endoscope – Endometriosis – Product Description 30

Optiscan Roboscope – Prostatectomy – Product Status 31

Optiscan Roboscope – Prostatectomy – Product Description 31

Optiscan System – Breast Cancer – Product Status 31

Optiscan System – Breast Cancer – Product Description 32

Rigid Endoscope – Liver Imaging – Product Status 32

Rigid Endoscope – Liver Imaging – Product Description 32

Optiscope Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

Optiscope – Product Status 33

Optiscope – Product Description 33

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 34

Ptychographic Endoscopic System – Product Status 34

Ptychographic Endoscopic System – Product Description 34

Volume Holographic Imaging System Endoscope – Product Status 35

Volume Holographic Imaging System Endoscope – Product Description 35

Glossary 95

Figures

Rigid Endoscopes – Pipeline Products by Stage of Development 9

Rigid Endoscopes – Pipeline Products by Segment 10

Rigid Endoscopes – Pipeline Products by Territory 11

Rigid Endoscopes – Pipeline Products by Regulatory Path 12

Rigid Endoscopes – Pipeline Products by Estimated Approval Date 13

Rigid Endoscopes – Ongoing Clinical Trials 14

Frequently asked questions

Rigid Endoscopes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Rigid Endoscopes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Rigid Endoscopes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 in real time.

  • Access a live Rigid Endoscopes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.